USC Norris
>
Clinical Trials
Not logged in...
About USC Norris
Research
Patient Care
Search Trials
FAQ - Trials
Contact Us - Trials
IRB
Membership
Education
Shared Resources
Support USC Norris
Login/Logout
» Contact Us
» Glossary
If you are a patient, please contact
Keck Medical Center of USC
at 800-USC-CARE.
Trial 3P-13-2
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination with Nab-Paclitaxel and Gemcitabine in Patients with Previously Untreated Stage IV Pancreatic Cancer
Type:
Treatment
Phase:
Phase I
Status:
Closed to Accrual with Ongoing Follow-up
Treatments:
Biological Response Modifier, Chemotherapy: Systemic
Randomized:
No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:
Heinz Josef Lenz, M.D.
Other Trial Staff:
Ramona Lujan, R.N., Yan Ning, D.M., Melissa Wallman, Coordinator, Sherine Elsayegh, D.M.
Staff may
log in
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
clinical.trials@med.usc.edu
.
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.